JP2025510700A5 - - Google Patents

Info

Publication number
JP2025510700A5
JP2025510700A5 JP2024556005A JP2024556005A JP2025510700A5 JP 2025510700 A5 JP2025510700 A5 JP 2025510700A5 JP 2024556005 A JP2024556005 A JP 2024556005A JP 2024556005 A JP2024556005 A JP 2024556005A JP 2025510700 A5 JP2025510700 A5 JP 2025510700A5
Authority
JP
Japan
Prior art keywords
antibody
antibody conjugate
linker
hetero
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024556005A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510700A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/057561 external-priority patent/WO2023180485A1/en
Publication of JP2025510700A publication Critical patent/JP2025510700A/ja
Publication of JP2025510700A5 publication Critical patent/JP2025510700A5/ja
Pending legal-status Critical Current

Links

JP2024556005A 2022-03-23 2023-03-23 Trop-2を発現する腫瘍を標的化するための抗体コンジュゲート Pending JP2025510700A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22163943 2022-03-23
EP22163943.8 2022-03-23
PCT/EP2023/057561 WO2023180485A1 (en) 2022-03-23 2023-03-23 Antibody-conjugates for targeting of tumours expressing trop-2

Publications (2)

Publication Number Publication Date
JP2025510700A JP2025510700A (ja) 2025-04-15
JP2025510700A5 true JP2025510700A5 (https=) 2026-03-31

Family

ID=81308125

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024556005A Pending JP2025510700A (ja) 2022-03-23 2023-03-23 Trop-2を発現する腫瘍を標的化するための抗体コンジュゲート

Country Status (10)

Country Link
US (1) US20250090679A1 (https=)
EP (1) EP4496594A1 (https=)
JP (1) JP2025510700A (https=)
KR (1) KR20250024743A (https=)
CN (1) CN119212731A (https=)
AU (1) AU2023241225A1 (https=)
CA (1) CA3253220A1 (https=)
IL (1) IL315207A (https=)
MX (1) MX2024011520A (https=)
WO (1) WO2023180485A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113260384A (zh) 2018-11-05 2021-08-13 西纳福克斯股份有限公司 用于靶向表达trop-2的肿瘤的抗体缀合物
IL315366A (en) 2022-03-23 2024-11-01 Synaffix Bv Antibody pairs for targeting PTK7-expressing tumors

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939255A (en) 1987-06-24 1990-07-03 Daiichi Pharmaceutical Co., Ltd. Hexa-cyclic camptothecin derivatives
EP0856054B1 (en) 1995-10-19 2004-04-28 Bristol-Myers Squibb Company Monoclonal antibody br110 and uses thereof
US9745380B2 (en) 2002-03-01 2017-08-29 Immunomedics, Inc. RS7 antibodies
CA2478047C (en) 2002-03-01 2014-01-21 Immunomedics, Inc. Rs7 antibodies
DK3438131T3 (da) 2006-02-10 2022-04-11 Life Technologies Corp Oligosaccharidmodifikation og mærkning af proteiner
US7420040B2 (en) 2006-02-24 2008-09-02 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of TROP-2
US20080131428A1 (en) 2006-02-24 2008-06-05 Arius Research, Inc. Cytotoxicity mediation of cells evidencing surface expression of TROP-2
WO2009102820A2 (en) 2008-02-11 2009-08-20 Government Of The U.S A., As Represented By The Secretary, Department Of Health And Human Services Modified sugar substrates and methods of use
CA2750038C (en) 2009-02-05 2016-10-04 Oncoxx S.R.L. Anti-trop-2 monoclonal antibodies and uses thereof in the treatment and diagnosis of tumors
WO2011155579A1 (ja) 2010-06-10 2011-12-15 北海道公立大学法人札幌医科大学 抗Trop-2抗体
TWI495644B (zh) 2011-11-11 2015-08-11 Rinat Neuroscience Corp 營養層細胞表面抗原(Trop-2)之專一性抗體類及彼等之用途
US9427464B2 (en) 2011-11-22 2016-08-30 Chiome Bioscience Inc. Anti-human TROP-2 antibody having an antitumor activity in vivo
CN105142672B (zh) 2012-10-23 2019-04-05 西纳福克斯股份有限公司 经修饰的抗体、抗体-缀合物及其制备方法
WO2015012904A2 (en) 2012-12-13 2015-01-29 Immunomedics, Inc. Antibody-sn-38 immunoconjugates with a cl2a linker
AU2014371934B2 (en) 2013-12-25 2020-01-23 Daiichi Sankyo Company, Limited Anti-TROP2 antibody-drug conjugate
EP4148138A1 (en) 2014-08-04 2023-03-15 SynAffix B.V. Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
CN107106701B (zh) 2014-10-03 2020-11-06 西纳福克斯股份有限公司 磺酰胺接头、其缀合物及制备方法
WO2016170186A1 (en) 2015-04-23 2016-10-27 Synaffix B.V. PROCESS FOR THE MODIFICATION OF A GLYCOPROTEIN USING A GLYCOSYLTRANSFERASE THAT IS OR IS DERIVED FROM A β(1,4)-N-ACETYLGALACTOSAMINYLTRANSFERASE
CA3026651A1 (en) 2016-06-09 2017-12-14 Blinkbio, Inc. Silanol based therapeutic payloads
TWI851577B (zh) 2018-06-07 2024-08-11 美商思進公司 喜樹鹼結合物
CN113260384A (zh) * 2018-11-05 2021-08-13 西纳福克斯股份有限公司 用于靶向表达trop-2的肿瘤的抗体缀合物
MX2021011812A (es) 2019-03-29 2021-10-22 Medimmune Ltd Compuestos y conjugados de estos.
SG11202110922QA (en) 2019-04-26 2021-10-28 Immunogen Inc Camptothecin derivatives
KR20230021018A (ko) 2020-06-05 2023-02-13 재단법인 생물기술개발중심 항-메조텔린 항체를 함유하는 항체-약물 컨쥬게이트 및 이의 용도
NL2026947B1 (en) 2020-11-20 2022-07-01 Synaffix Bv Tyrosine-based antibody conjugates
CN113816969B (zh) 2021-04-30 2024-01-16 联宁(苏州)生物制药有限公司 依喜替康类化合物、其抗体药物偶联物及其应用
KR20230015301A (ko) 2021-07-19 2023-01-31 맙플렉스 인터내셔널 컴퍼니 리미티드 2성분 독소가 부하된 항체-약물 접합체 및 그의 용도

Similar Documents

Publication Publication Date Title
JP2025510700A5 (https=)
Chittaboina et al. One-pot synthesis of triazole-linked glycoconjugates
US20090181402A1 (en) Compositions and methods for coupling a plurality of compounds to a scaffold
US10030066B2 (en) Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor
JP2020000252A5 (https=)
CN113260384A (zh) 用于靶向表达trop-2的肿瘤的抗体缀合物
CN113301920A (zh) 包含配体、间隔物、肽接头和生物分子的复合物
WO2011162252A1 (ja) 分岐型ヘテロポリエチレングリコールおよび中間体
AU2013237497B2 (en) Carbohydrate-glycolipid conjugate vaccines
EP2121030A2 (en) Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites
US20120322955A1 (en) Polyoxyethylene derivative having plural hydroxyl groups at terminal end thereof
US20200261560A1 (en) Precision glycoconjugates as therapeutic tools
US9365598B2 (en) Phosphine derivatives of fluorescent compounds
JP2025510678A5 (https=)
JP2025111561A (ja) 化合物またはその塩、およびそれらにより得られる抗体
JP5612467B2 (ja) Fmocをベースとした加水分解性リンカーの調製方法
JP2015157946A (ja) 分岐型ヘテロポリエチレングリコールおよび中間体
JP2908558B2 (ja) 炭水化物のアクリル及びメタクリルコポリマー並びに該ポリマーの製造方法
US20240252652A1 (en) Proteins having unnatural amino acids and methods of use
Lee et al. Synthesis of MUC1 Neo glycopeptides using efficient microwave-enhanced chaotrope-assisted click chemistry
JP2012502011A5 (https=)
CN109305936B (zh) 一种化合物及其制备方法和在抗体药物偶联物制备中的用途
US8129505B2 (en) Comb polymers
CN1742057A (zh) 用于荧光诊断的亲水性硫醇反应性花青染料及其与生物分子的缀合物
Liu et al. Novel Base‐Labile Linkers for Convenient Purification and Functional Group Introduction in Solid‐Phase Glycan Synthesis